Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Dose-Finding Study and a Randomized Phase II Study of ALIMTA Plus Oxaliplatin Versus Oxaliplatin Plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) in the First-Line Treatment of Patients With Locally Advanced Unresectable or Stage IV Colorectal Cancer

NCT00166465 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00166465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00166465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Dose-Finding Study and a Randomized Phase II Study of ALIMTA Plus Oxaliplatin Versus Oxaliplatin Plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen) in the First-Line Treatment of Patients With Locally Advanced Unresectable or Stage IV Colorectal Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2003
Completion date
June 30, 2006
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced unresectable or stage iv colorectal cancer